Koji Kishi

Title: Koji Kishi: Innovator in Biochemical Assays

Introduction

Koji Kishi is a notable inventor based in Kobe, Japan, recognized for his contributions to the field of biochemical assays. He holds a total of four patents, showcasing his innovative approach to medical diagnostics and enzyme assays. His work has significantly impacted the way specific components in lipoproteins are quantified, enhancing the accuracy of various medical tests.

Latest Patents

Kishi's latest patents include a reagent set and method for detecting cholesterol in high-density lipoprotein (HDL) and low-density lipoprotein (LDL). This method allows for the quantitation of specific components in lipoproteins contained in biological samples without the need for centrifugation or causing cloudiness in the reaction liquor. Additionally, he has developed a method for accurately assaying the enzyme activities of mitochondrial creatine kinase (mCK) isozymes. This invention utilizes antibodies that specifically recognize umCK protein, enabling separate assays for ubiquitous mCK and sarcomeric mCK.

Career Highlights

Throughout his career, Koji Kishi has worked with prominent companies such as Sysmex Corporation and International Reagents Corporation. His experience in these organizations has allowed him to refine his skills and contribute to advancements in biochemical testing technologies.

Collaborations

Kishi has collaborated with notable colleagues, including Tsutomu Kakuyama and Koji Ochiai. These partnerships have fostered innovation and the development of new methodologies in the field of enzyme assays.

Conclusion

Koji Kishi's work in the realm of biochemical assays exemplifies the importance of innovation in medical diagnostics. His patents reflect a commitment to improving the accuracy and efficiency of enzyme assays, ultimately benefiting the healthcare industry.